Editorial: Insights in coronary artery disease: 2023
- PMID: 40443970
- PMCID: PMC12119649
- DOI: 10.3389/fcvm.2025.1619625
Editorial: Insights in coronary artery disease: 2023
Keywords: atherosclerosis; coronary artery disease; inflammation; myocardial infarction; percutaneous coronar intervention.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Insights in coronary artery disease: 2023
References
-
- Gargiulo P, Basile C, Galasso G, Bellino M, D'Elia D, Patti G, et al. Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the at-target-it registry. Eur J Prev Cardiol. (2024) 31(15):1806–16. 10.1093/eurjpc/zwae170 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
